Cargando…

TUBB3 overexpression has a negligible effect on the sensitivity to taxol in cultured cell lines

Microtubules are cellular targets for a variety of anticancer therapies because of their critical function in mitosis. Taxol belongs to a class of microtubule targeting agents that suppresses microtubule dynamics and interferes with the functioning of the mitotic spindle, thereby effectively blockin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tame, Mihoko A., Manjón, Anna G., Belokhvostova, Daria, Raaijmakers, Jonne A., Medema, René H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641069/
https://www.ncbi.nlm.nih.gov/pubmed/29069726
http://dx.doi.org/10.18632/oncotarget.17740
_version_ 1783271152107388928
author Tame, Mihoko A.
Manjón, Anna G.
Belokhvostova, Daria
Raaijmakers, Jonne A.
Medema, René H.
author_facet Tame, Mihoko A.
Manjón, Anna G.
Belokhvostova, Daria
Raaijmakers, Jonne A.
Medema, René H.
author_sort Tame, Mihoko A.
collection PubMed
description Microtubules are cellular targets for a variety of anticancer therapies because of their critical function in mitosis. Taxol belongs to a class of microtubule targeting agents that suppresses microtubule dynamics and interferes with the functioning of the mitotic spindle, thereby effectively blocking cell cycle progression of rapidly proliferating tumor cells. Despite its antitumor activity, drug resistance remains a common obstacle in improving its overall clinical efficacy. Previous studies have shown that the expression of a specific β-tubulin isotype, βIII-tubulin/TUBB3, is dysregulated in drug-refractory tumors. However, whether enhanced TUBB3 expression is directly involved in promoting taxol resistance remains a subject of debate. Here, we have used several approaches to assess the functional relation of TUBB3 overexpression and taxol resistance. First, we generated a number of taxol-resistant cell lines, to find that TUBB3 expression was elevated in a resistant cell line (RPE-20) derived from untransformed retinal pigment epithelial (RPE) cells, but the abundance of TUBB3 remained unchanged in four other cell lines after taxol treatment. However, although RPE-20 cells displayed enhanced TUBB3 levels, we find that simultaneous up-regulation of the P-glycoprotein (P-gP) drug-efflux pump is responsible for the resistance to taxol. Indeed, we could show that TUBB3 levels were dynamically regulated upon taxol exposure and withdrawal, unrelated to the resistance phenotype. Next, we generated cell lines in which we could induce robust overexpression of TUBB3 from its endogenous locus employing the CRISPRa system. We demonstrate that solely enhancing TUBB3 expression results in a very minor decrease in the sensitivity to taxol. This was further substantiated by selective depletion of TUBB3 in a series of breast cancer cell lines expressing high levels of TUBB3. We find that TUBB3 depletion had a minimal effect on the sensitivity to taxol in one of these cell lines, but had no effect in all of the others. Based on these findings we propose that TUBB3 overexpression can only marginally affect the sensitivity to taxol in cultured cell lines.
format Online
Article
Text
id pubmed-5641069
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56410692017-10-24 TUBB3 overexpression has a negligible effect on the sensitivity to taxol in cultured cell lines Tame, Mihoko A. Manjón, Anna G. Belokhvostova, Daria Raaijmakers, Jonne A. Medema, René H. Oncotarget Research Paper Microtubules are cellular targets for a variety of anticancer therapies because of their critical function in mitosis. Taxol belongs to a class of microtubule targeting agents that suppresses microtubule dynamics and interferes with the functioning of the mitotic spindle, thereby effectively blocking cell cycle progression of rapidly proliferating tumor cells. Despite its antitumor activity, drug resistance remains a common obstacle in improving its overall clinical efficacy. Previous studies have shown that the expression of a specific β-tubulin isotype, βIII-tubulin/TUBB3, is dysregulated in drug-refractory tumors. However, whether enhanced TUBB3 expression is directly involved in promoting taxol resistance remains a subject of debate. Here, we have used several approaches to assess the functional relation of TUBB3 overexpression and taxol resistance. First, we generated a number of taxol-resistant cell lines, to find that TUBB3 expression was elevated in a resistant cell line (RPE-20) derived from untransformed retinal pigment epithelial (RPE) cells, but the abundance of TUBB3 remained unchanged in four other cell lines after taxol treatment. However, although RPE-20 cells displayed enhanced TUBB3 levels, we find that simultaneous up-regulation of the P-glycoprotein (P-gP) drug-efflux pump is responsible for the resistance to taxol. Indeed, we could show that TUBB3 levels were dynamically regulated upon taxol exposure and withdrawal, unrelated to the resistance phenotype. Next, we generated cell lines in which we could induce robust overexpression of TUBB3 from its endogenous locus employing the CRISPRa system. We demonstrate that solely enhancing TUBB3 expression results in a very minor decrease in the sensitivity to taxol. This was further substantiated by selective depletion of TUBB3 in a series of breast cancer cell lines expressing high levels of TUBB3. We find that TUBB3 depletion had a minimal effect on the sensitivity to taxol in one of these cell lines, but had no effect in all of the others. Based on these findings we propose that TUBB3 overexpression can only marginally affect the sensitivity to taxol in cultured cell lines. Impact Journals LLC 2017-05-10 /pmc/articles/PMC5641069/ /pubmed/29069726 http://dx.doi.org/10.18632/oncotarget.17740 Text en Copyright: © 2017 Tame et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research Paper
Tame, Mihoko A.
Manjón, Anna G.
Belokhvostova, Daria
Raaijmakers, Jonne A.
Medema, René H.
TUBB3 overexpression has a negligible effect on the sensitivity to taxol in cultured cell lines
title TUBB3 overexpression has a negligible effect on the sensitivity to taxol in cultured cell lines
title_full TUBB3 overexpression has a negligible effect on the sensitivity to taxol in cultured cell lines
title_fullStr TUBB3 overexpression has a negligible effect on the sensitivity to taxol in cultured cell lines
title_full_unstemmed TUBB3 overexpression has a negligible effect on the sensitivity to taxol in cultured cell lines
title_short TUBB3 overexpression has a negligible effect on the sensitivity to taxol in cultured cell lines
title_sort tubb3 overexpression has a negligible effect on the sensitivity to taxol in cultured cell lines
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641069/
https://www.ncbi.nlm.nih.gov/pubmed/29069726
http://dx.doi.org/10.18632/oncotarget.17740
work_keys_str_mv AT tamemihokoa tubb3overexpressionhasanegligibleeffectonthesensitivitytotaxolinculturedcelllines
AT manjonannag tubb3overexpressionhasanegligibleeffectonthesensitivitytotaxolinculturedcelllines
AT belokhvostovadaria tubb3overexpressionhasanegligibleeffectonthesensitivitytotaxolinculturedcelllines
AT raaijmakersjonnea tubb3overexpressionhasanegligibleeffectonthesensitivitytotaxolinculturedcelllines
AT medemareneh tubb3overexpressionhasanegligibleeffectonthesensitivitytotaxolinculturedcelllines